Current Assets: The sum of all assets that are classified as current, because they will provide a benefit within one year.
Anavex Life Sciences Corp. (AVXL) had Current Assets of $120.14M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$7.82M |
|
-- |
|
-- |
|
$-6.74M |
|
$6.74M |
|
$1.09M |
|
$7.82M |
|
$7.82M |
|
$7.82M |
|
$7.82M |
|
$7.82M |
|
$7.82M |
|
$6.74M |
|
$6.74M |
|
92.70M |
|
92.90M |
|
$0.08 |
|
$0.08 |
|
| Balance Sheet Financials | |
|
Current Assets |
$120.14M |
-- |
|
-- |
|
$120.14M |
|
$7.69M |
|
-- |
|
-- |
|
$7.69M |
|
$112.45M |
|
$112.45M |
|
$112.45M |
|
92.70M |
|
| Cash Flow Statement Financials | |
$-20.69M |
|
-- |
|
$36.44M |
|
$102.58M |
|
$118.33M |
|
$15.75M |
|
$-15.66M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
15.62 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-20.69M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
6.96% |
|
6.96% |
|
6.51% |
|
6.96% |
|
$1.21 |
|
$-0.22 |
|
$-0.22 |
|